Trial Profile
A Retrospective study to evaluate the efficacy and safety of Brincidofovir for Disseminated Adenovirus in Kidney and Kidney-Pancreas Transplant Recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2018
Price :
$35
*
At a glance
- Drugs Brincidofovir (Primary)
- Indications Adenovirus infections
- Focus Adverse reactions; Therapeutic Use
- 12 Jul 2018 New trial record
- 06 Jun 2018 Results presented at the 2018 American Transplant Congress